PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

Completed · Phase 2

Conditions studied: Hepatitis B

In brief

Open-label pharmacokinetic drug interaction study.

Key facts

Study ID

NCT00644761

Run by

Gilead Sciences

People needed

16

Starts

2004-02-01

Expected to finish

2005-05-01

Last updated by the study team

2008-04-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-65 years of age
• Greater than or equal to 6 months post-liver transplantation
• Must be on a documented stable total daily dose of tacrolimus or cyclosporine for three months.
• Must have calculated creatinine clearance greater than or equal 50 mL/min (Cockcroft-Gault method).

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Cedars Sinai Medical Center — Los Angeles, California, United States
• California Pacific Medical Center — San Francisco, California, United States
• University of California, San Francisco — San Francisco, California, United States
• University of Miami — Miami, Florida, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• NYU Medical Center — New York, New York, United States
• Columbia Presbyterian Medical Center — New York, New York, United States
• Mayo Clinic — Rochester, New York, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• Baylor Research Institute — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.